TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IPD Stock 12 Month Forecast
Average Price Target
AU$0.09
▲(126.28% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Impedimed Limited in the last 3 months. The average price target is AU$0.09 with a high forecast of AU$0.14 and a low forecast of AU$0.08. The average price target represents a 126.28% change from the last price of AU$0.04.
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +4.70% per trade.
trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of +17.70% per trade.
Copying Scott Power's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +7.35% per trade.
trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of +18.41% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IPD Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
4
4
6
4
5
Buy
0
0
0
0
0
Hold
10
9
7
6
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
13
13
10
10
In the current month, IPD has received 5Buy Ratings, 5Hold Ratings, and 0Sell Ratings. IPD average Analyst price target in the past 3 months is 0.09.
Each month's total comprises the sum of three months' worth of ratings.
IPD Financial Forecast
IPD Earnings Forecast
Next quarter’s earnings estimate for IPD is AU$0.00 with a range of AU$0.00 to AU$0.00. The previous quarter’s EPS was ―. IPD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year IPD has Performed in-line its overall industry.
Next quarter’s earnings estimate for IPD is AU$0.00 with a range of AU$0.00 to AU$0.00. The previous quarter’s EPS was ―. IPD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year IPD has Performed in-line its overall industry.
IPD Sales Forecast
Next quarter’s sales forecast for IPD is AU$4.80M with a range of AU$4.80M to AU$4.80M. The previous quarter’s sales results were ―. IPD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year IPD has Performed in-line its overall industry.
Next quarter’s sales forecast for IPD is AU$4.80M with a range of AU$4.80M to AU$4.80M. The previous quarter’s sales results were ―. IPD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year IPD has Performed in-line its overall industry.
IPD Stock Forecast FAQ
What is AU:IPD’s average 12-month price target, according to analysts?
Based on analyst ratings, Impedimed Limited’s 12-month average price target is 0.09.
What is AU:IPD’s upside potential, based on the analysts’ average price target?
Impedimed Limited has 126.28% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Impedimed Limited a Buy, Sell or Hold?
Impedimed Limited has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Impedimed Limited’s share price target?
The average share price target for Impedimed Limited is 0.09. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is AU$0.14 ,and the lowest forecast is AU$0.08. The average share price target represents 126.28% Increase from the current price of <AU$0.1.
What do analysts say about Impedimed Limited?
Impedimed Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Impedimed Limited?
To buy shares of AU:IPD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.